Policy & Regulation

After semaglutide patent expiry in India, 40+ drugmakers and 50+ brands rushed in, with monthly treatment prices falling to about US$14, pushing GLP-1 into fully open competition in a large market for the first time.

Brazil expanded chemical tax relief while India’s crop protection industry warned that input costs could rise 25%, showing the Middle East conflict is spreading from oil prices into industrial policy and agricultural security.

EFSA’s latest review keeps clodinafop under pressure by highlighting missing data and key risk concerns.

The FDA added another noteworthy nutrition-related development on March 16, when it posted the agenda and memo for a March 27 public meeting titled “Exploring the Scope of Dietary Supplement Ingredients.”

A quieter but potentially important nutrition story emerged in mid-March when the FDA published a memorandum of understanding with the National Institutes of Health to coordinate the NIH-FDA Nutrition Regulatory Science Program.

The agency said the assessment evaluated how pathogens such as Salmonella, STEC O157:H7, and STEC non-O157 can survive, move through the farm environment, and ultimately reach consumers through contaminated produce.

WACKER posted a €805 million net loss in 2025, while its PACE savings plan is now central to any recovery in 2026.

Key 2026 pharmaceutical regulatory updates across UAE, Saudi Arabia, GCC, Egypt and global agencies, with practical compliance insights for pharma companies.

• UAE
• MENA region
• Drugs
• Regulation
• pharmaceutical policy

Over the past 72 hours, the security situation in key Middle Eastern maritime corridors — the Strait of Hormuz and the Red Sea — has deteriorated again.

FDA loosens “no artificial colors” claims while green-lighting new natural dyes—sparking a fierce debate over what “clean” really means.

FDA reopens BHA safety review, signaling a global shift toward tighter oversight of legacy food additives.

Key ECHA regulatory updates affecting REACH, CLP, and Drinking Water compliance. Practical guidance for EU chemical operators.

• Echa
• REACH
• CLP

Gone are the days when “boosts plant vitality” or “enhances natural defenses” could carry a bio-stimulant to market in Europe. Under the ironclad framework of the EU Fertilising Products Regulation (FPR) (EU) 2019/1009, the era of concept-driven marketing

Ministry of Health, Labour and Welfare (MHLW) has unveiled a nuanced revision to its food additive standards—one that simultaneously restricts one ingredient while expanding another’s use in everyday beverages.

U.S. Food and Drug Administration (FDA) took an action that offered palpable relief to the global weight-loss drug market: it instructed pharmaceutical companies to remove warnings about “suicidal ideation and suicidal behavior” from the labels of certain

On December 23, 2025, Beijing Oriental Yuhong Waterproof Technology Co., Ltd.issued a startling announcement: its wholly owned U.S. subsidiary, OYH Construction Materials LLC, had likely fallen victim to a sophisticated telecom fraud scheme.

The global pesticide market has entered a period of stagnation and downward pressure, with weak demand and oversupply pushing most active ingredients into a prolonged correction phase.

In a landmark regulatory first, the U.S. FDA has qualified its first artificial-intelligence tool designed to accelerate liver-disease drug development, validating AI as an official decision-support instrument in pharmaceutical research.